File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Standardization of organoid culture in cancer research

TitleStandardization of organoid culture in cancer research
Authors
Keywordsextracellular matrix
organoid culture system
standardization
tumor microenvironment
tumor organoids
Issue Date20-Apr-2023
PublisherWiley Open Access
Citation
Cancer Medicine, 2023, v. 12, n. 13, p. 14375-14386 How to Cite?
Abstract

Establishing a valid in vitro model to represent tumor heterogeneity and biology is critical but challenging. Tumor organoids are self-assembled three-dimensional cell clusters which are of great significance for recapitulating the histopathological, genetic, and phenotypic characteristics of primary tissues. The organoid has emerged as an attractive in vitro platform for tumor biology research and high-throughput drug screening in cancer medicine. Organoids offer unique advantages over cell lines and patient-derived xenograft models, but there are no standardized methods to guide the culture of organoids, leading to confusion in organoid studies that may affect accurate judgments of tumor biology. This review summarizes the shortcomings of current organoid culture methods, presents the latest research findings on organoid standardization, and proposes an outlook for organoid modeling.


Persistent Identifierhttp://hdl.handle.net/10722/338829
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.174
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhou, Changchun-
dc.contributor.authorWu, Yuanbo-
dc.contributor.authorWang, Zeyu-
dc.contributor.authorLiu, Yanli-
dc.contributor.authorYu, Jiaqi-
dc.contributor.authorWang, Weiping-
dc.contributor.authorChen, Sunrui-
dc.contributor.authorWu, Weihua-
dc.contributor.authorWang, Jidong-
dc.contributor.authorQian, Guowei-
dc.contributor.authorHe, Aina-
dc.date.accessioned2024-03-11T10:31:51Z-
dc.date.available2024-03-11T10:31:51Z-
dc.date.issued2023-04-20-
dc.identifier.citationCancer Medicine, 2023, v. 12, n. 13, p. 14375-14386-
dc.identifier.issn2045-7634-
dc.identifier.urihttp://hdl.handle.net/10722/338829-
dc.description.abstract<p>Establishing a valid in vitro model to represent tumor heterogeneity and biology is critical but challenging. Tumor organoids are self-assembled three-dimensional cell clusters which are of great significance for recapitulating the histopathological, genetic, and phenotypic characteristics of primary tissues. The organoid has emerged as an attractive in vitro platform for tumor biology research and high-throughput drug screening in cancer medicine. Organoids offer unique advantages over cell lines and patient-derived xenograft models, but there are no standardized methods to guide the culture of organoids, leading to confusion in organoid studies that may affect accurate judgments of tumor biology. This review summarizes the shortcomings of current organoid culture methods, presents the latest research findings on organoid standardization, and proposes an outlook for organoid modeling.</p>-
dc.languageeng-
dc.publisherWiley Open Access-
dc.relation.ispartofCancer Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectextracellular matrix-
dc.subjectorganoid culture system-
dc.subjectstandardization-
dc.subjecttumor microenvironment-
dc.subjecttumor organoids-
dc.titleStandardization of organoid culture in cancer research-
dc.typeArticle-
dc.identifier.doi10.1002/cam4.5943-
dc.identifier.scopuseid_2-s2.0-85153336119-
dc.identifier.volume12-
dc.identifier.issue13-
dc.identifier.spage14375-
dc.identifier.epage14386-
dc.identifier.eissn2045-7634-
dc.identifier.isiWOS:000972793400001-
dc.identifier.issnl2045-7634-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats